Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy
-
Núria Bertran
Abstract
C-Reactive protein has been associated with several complications of pregnancy. The aims of the present study were: (1) to evaluate a turbidimetric immunoassay for the measurement of C-reactive protein; and (2) to investigate the chronological changes of the levels of this protein from preconception throughout normal pregnancy and its relationship with variables associated with preconception and pregnancy outcome. Inter-assay imprecision was <5% for C-reactive protein >1mg/L and 18% at a mean value of 0.33mg/L. The limit of detection was 0.10mg/L. The method was linear between 0.10 and 30mg/L. There were no observed interferences from jaundice, hemolysis, lipemia or paraproteinemia at the levels studied. There was good agreement with the nephelometric method. A total of 39 women were studied at preconception, at 8, 20 and 32weeks of pregnancy, and in labor. Preconception C-reactive protein concentration was 1.17±0.18mg/L and increased (p<0.001) throughout pregnancy up to 5.69±0.82mg/L. Body mass index at preconception and weight gain during pregnancy were the main factors associated with this increase in C-reactive protein.
References
1 Pickup JC, Crook MA. Is type 2 DM a disease of the innate immune system? Diabetologia 1998; 41: 1241–8. 10.1007/s001250051058Suche in Google Scholar PubMed
2 Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–92. 10.1007/s001250050822Suche in Google Scholar PubMed
3 Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000; 102: 42–7. 10.1161/01.CIR.102.1.42Suche in Google Scholar PubMed
4 Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, ant endothelial dysfunction. Arterioscler Thromb Vasc Biol 1999; 19: 972–8. 10.1161/01.ATV.19.4.972Suche in Google Scholar
5 Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26. 10.1056/NEJM199901143400207Suche in Google Scholar PubMed
6 Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheught FW, Wolbink GJ, et al. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999; 100: 96–102. 10.1161/01.CIR.100.1.96Suche in Google Scholar
7 Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–43. 10.1056/NEJM200003233421202Suche in Google Scholar PubMed
8 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [erratum appears in N Engl J Med 1997;337:356]. N Engl J Med 1997; 336: 973–9. 10.1056/NEJM199704033361401Suche in Google Scholar PubMed
9 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425–8. 10.1161/01.CIR.97.5.425Suche in Google Scholar
10 Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731–3. 10.1161/01.CIR.98.8.731Suche in Google Scholar
11 Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5–15. 10.1055/s-2007-1016248Suche in Google Scholar
12 Catalano PM. Obesity and pregnancy – the propagation of a vicious cycle? [editorial]. J Clin Endocr Metab 2003; 88: 3505–6. 10.1210/jc.2003-031046Suche in Google Scholar
13 Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-Reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocr Metab 2003; 88: 3507–12. 10.1210/jc.2003-030186Suche in Google Scholar
14 Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26: 819–24. 10.2337/diacare.26.3.819Suche in Google Scholar
15 Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59: 29–37. 10.1016/S0165-0378(02)00085-2Suche in Google Scholar
16 Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001; 98: 757–62. 10.1097/00006250-200111000-00009Suche in Google Scholar
17 Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001; 47: 403–11. 10.1093/clinchem/47.3.403Suche in Google Scholar
18 Simó JM, Joven J, Clivillé X, Sans T. Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer. Clin Chem 1994; 40: 625–29. 10.1093/clinchem/40.4.625Suche in Google Scholar
19 Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002; 76: 614–19. 10.1093/ajcn/76.3.614Suche in Google Scholar PubMed
20 Ferré N, Camps J, Prats E, Girona J, Gómez F, Heras M, et al. Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma. Metabolism 2002; 51: 609–15. 10.1053/meta.2002.32016Suche in Google Scholar PubMed
21 Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000; 46: 100–4. 10.1093/clinchem/46.1.100Suche in Google Scholar
22 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307–10. 10.1016/S0140-6736(86)90837-8Suche in Google Scholar
23 Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000; 46: 461–8. 10.1093/clinchem/46.4.461Suche in Google Scholar
24 Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001; 47: 418–25. 10.1093/clinchem/47.3.418Suche in Google Scholar
25 Hamwi A, Vukovich T, Wagner O, Rumpold H, Spies R, Stich M, Langecker C. Evaluation of turbidimetric high-sensitivity C-reactive protein assays for cardiovascular risk estimation. Clin Chem 2001; 47: 2044–6. 10.1093/clinchem/47.11.2044Suche in Google Scholar
26 De BK, Smith LG, Owen WE, Roberts WL. Performance characteristics of an automated high-sensitivity C-protein assay on the Dimension RXL analyzer. Clin Chim Acta 2002; 323: 151–5. 10.1016/S0009-8981(02)00185-7Suche in Google Scholar
27 Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003; 49: 1258–71. 10.1373/49.8.1258Suche in Google Scholar PubMed
28 Keski-Nisula L, Kirkinen P, Ollikainen M, Saarikoski S. C-Reactive protein in uncomplicated parturients delivered by cesarean section. Acta Obstet Gynecol Scand 1997; 76: 862–7. 10.3109/00016349709024366Suche in Google Scholar PubMed
29 Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-Reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand 2002; 81: 424–9. 10.1034/j.1600-0412.2002.810509.xSuche in Google Scholar PubMed
30 Ramsay JE, Ferrell WR, Crawford L, Wallace MA, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87: 4231–7. 10.1210/jc.2002-020311Suche in Google Scholar PubMed
©2005 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock
- Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells
- Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
- Assessment of iodine intake in mildly iodine-deficient pregnant women by a new automated kinetic urinary iodine determination method
- Butyrylcholinesterase activity and metabolic syndrome in obese patients
- The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study
- Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique
- Quality control in urinary stone analysis: results of 44 ring trials (1980–2001)
- External Quality Assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch “Calibration 2000” project
- Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy
- A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses
- Preanalytical variability in laboratory testing: influence of the blood drawing technique
- Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis
- Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment
- The number of consultant clinical chemists in the 15-nation European Union
- Biological variation of vascular endothelial growth factor
- Terminology, categories and representation of examinations in laboratory medicine
- Reply to W.G. Wood. Questionable results – who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073
- The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma
- 4th Conference on Hyperhomocysteinemia: Saarbrücken, Germany, April, 14–16, 2005, Saarland University
Artikel in diesem Heft
- Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock
- Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells
- Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
- Assessment of iodine intake in mildly iodine-deficient pregnant women by a new automated kinetic urinary iodine determination method
- Butyrylcholinesterase activity and metabolic syndrome in obese patients
- The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study
- Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique
- Quality control in urinary stone analysis: results of 44 ring trials (1980–2001)
- External Quality Assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch “Calibration 2000” project
- Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy
- A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses
- Preanalytical variability in laboratory testing: influence of the blood drawing technique
- Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis
- Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment
- The number of consultant clinical chemists in the 15-nation European Union
- Biological variation of vascular endothelial growth factor
- Terminology, categories and representation of examinations in laboratory medicine
- Reply to W.G. Wood. Questionable results – who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073
- The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma
- 4th Conference on Hyperhomocysteinemia: Saarbrücken, Germany, April, 14–16, 2005, Saarland University
